Daniel S. Goldbaum
Papers
1
Total Citations
4
H-Index
1
About
Daniel S. Goldbaum is a clinician-researcher whose work bridges the fields of radiation oncology and neuro-oncology, with a particular focus on the interplay between immunotherapy and stereotactic radiosurgery for brain metastases. His most cited study, "Does Immunotherapy Influence the Risk of Developing Radiation Necrosis After Radiosurgery of Brain Metastases?" (2017), addresses a critical clinical question: whether combining immune checkpoint inhibitors with radiosurgery elevates the risk of radiation necrosis, a severe complication. This work has garnered attention for its practical implications in treatment planning, accumulating 4 citations as a foundational reference in the emerging literature on combined-modality therapy. Goldbaum’s research helps guide oncologists in balancing therapeutic efficacy against toxicity, a key challenge in managing metastatic disease. His contributions underscore the importance of understanding synergistic effects between systemic immunotherapy and localized radiation, offering insights that directly impact patient outcomes. As the field evolves, his work remains a touchstone for investigators exploring the safety and optimization of these powerful treatment combinations.
Research Focus
Key Achievements
Top Papers
- 1